* drugs
** isoniazid
*** mechanism of action
Block synthesis of mycolic acids
*** adverse effects
peripheral neuropathy
*** counseling
administer with vitamin B6 / pyridoxine
*** pharmacokinetics
- acetylated in liver
- slow acetylators (a small population in the USA) will have higher drug levels
** INH, Ethionamide
*** mechanism of action
Block synthesis of mycolic acids
*** target
acyl carrier protein, b-keto acyl carrier protein, FAS II
** Pyrazinamide
*** mechanism of action
Inhibit cell membrane metabolism and transport functions
*** target
Fatty acid synthetase I (FAS I)??
** Rifampin/rifapentin
*** mechanism of action
Inhibit RNA synthesis
*** target
RNA polymerase
** Ethambutol
*** mechanism of action
Inhibit cell wall synthesis (arabinogalactan)
*** target
Arabynosyl transferase
** Streptomycin/kanamycin, Capreomycin, Amikacin
*** mechanism of action
Inhibit protein synthesis
*** target
30s ribosomal subunit
** Fluoroquinolones
*** mechanism of action
Inhibit DNA replication
*** target
Topoisomerase II and IV
** PAS, Dapsone
*** mechanism of action
Inhibit folate synthesis
*** target
Dihydropteroate synthase
** Clofazimine
*** mechanism of action
Inhibit transcription
*** target
DNA template
** Cycloserine
*** mechanism of action
Inhibit peptidoglycan synthesis
*** target
Alanine racemase (L-alanine to D-alanine)
** Bedaquiline
*** mechanism of action
Inhibits ATP synthesis
*** target
Proton pump 
* tuberculosis
** drug-sensitive
*** treatment
- isoniazid
- rifampin
- pyrazinamide
- ethambutol
* prodrugs :l:
** pyrazinamide
* drugs with toxicity
** hepatotoxicity
** nephrotoxicity
** neuropathy
*** mitigation
supplementation with vitamin B6
*** [#B] drugs
- isoniazid
- cycloserine
- ethionamide
